3SBio Inc. (HKG:1530)
Hong Kong · Delayed Price · Currency is HKD 27.50
-0.64 (-2.27%)
Jan 8, 2026, 4:08 PM HKT
3SBio Market Cap
3SBio has a market cap or net worth of 70.28 billion as of January 8, 2026. Its market cap has increased by 370.69% in one year.
Market Cap
70.28B
Enterprise Value
68.13B
Revenue
9.94B
Ranking
n/a
PE Ratio
26.78
Stock Price
27.50
Market Cap Chart
Since June 11, 2015, 3SBio's market cap has increased from 22.67B to 70.28B, an increase of 210.06%. That is a compound annual growth rate of 11.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 70.28B | 16.38% |
| Dec 31, 2025 | 60.39B | 321.75% |
| Dec 31, 2024 | 14.32B | -20.61% |
| Dec 29, 2023 | 18.04B | -10.89% |
| Dec 30, 2022 | 20.24B | 23.46% |
| Dec 31, 2021 | 16.40B | -8.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 276.04B |
| Hansoh Pharmaceutical Group Company | 242.40B |
| JD Health International | 197.37B |
| Innovent Biologics | 153.24B |
| WuXi Biologics | 149.11B |
| Sino Biopharmaceutical | 122.10B |
| Akeso | 119.01B |
| Sichuan Kelun-Biotech Biopharmaceutical | 110.48B |